Bio Medica Laboratories Limited (NSE:BMLL)

India · Delayed Price · Currency is INR

164.50

-3.30 (-1.97%)

At close: Oct 16, 2026

Market Cap	2.07B
Revenue (ttm)	430.90M +103.0%
Net Income	117.81M +1,900.1%
EPS	12.83
Shares Out	12.58M
PE Ratio	12.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,000
Open	156.00
Previous Close	167.80
Day's Range	156.00 - 167.00
52-Week Range	101.50 - 181.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 27, 2026

About Bio Medica Laboratories

Bio Medica Laboratories Limited engages in manufacturing, marketing, trading, import and export of pharmaceutical products in India. The company offers medicines; bulk drugs; and chemicals and allied healthcare products, including antibiotic, ayurvedic, allopathic, and homeopathic products, as well as operates hospitals, clinics, diagnostic centers, laboratories, and other healthcare facilities, including medical research and related healthcare services. It also provides human and veterinary injectables products. The company was formerly known ... [Read more]

Industry Pharmaceutical Preparations

Founded 1988

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol BMLL

Full Company Profile

Financial Performance

In fiscal year 2026, Bio Medica Laboratories's revenue was 430.90 million, an increase of 12.81% compared to the previous year's 381.95 million. Earnings were 117.81 million, an increase of 20.27%.

Financial Statements